A drug-sensitizing RNA interaction of HIV-1 reverse transcriptase.
Bailey
J M
JM
Dept. of Biochemistry and Molecular Biology, George Washington University Medical School, Washington, D.C.
Lightfoote
M
M
D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology*; D002460:Cell Line; D004926:Escherichia coli / Q000235:genetics; D017245:Foscarnet / Q000494:pharmacology*; D016679:Genome, Viral; D054303:HIV Reverse Transcriptase; D015497:HIV-1 / Q000187:drug effects / Q000201:enzymology*; D006801:Humans; D007700:Kinetics; D012367:RNA, Viral / Q000378:metabolism*; D012194:RNA-Directed DNA Polymerase / Q000235:genetics / Q000302:isolation & purification; D011994:Recombinant Proteins / Q000037:antagonists & inhibitors / Q000302:isolation & purification; D018894:Reverse Transcriptase Inhibitors; D014162:Transfection; D014709:Vero Cells
D000998:Antiviral Agents; D012367:RNA, Viral; D011994:Recombinant Proteins; D018894:Reverse Transcriptase Inhibitors; D017245:Foscarnet; D054303:HIV Reverse Transcriptase; D012194:RNA-Directed DNA Polymerase